Pharma News, 2019

Matt Hancock hails ‘game-changer’ but critics raise racial bias and ‘fatalism’ concerns.

OTTAWA (Reuters) - Canada will create a national drug agency to help cut the cost of prescription medications as part of a plan to broaden the state-funded healthcare program, the finance mini...

(Reuters) - A U.

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart&#...

Low levels of amyloid-β and tau proteins, biomarkers of Alzheimer's disease (AD), in eye fluid were significantly associated with low cognitive scores, according to a new study published ...

Introducing hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 percent, according to a study in which the University of Barcelona (UB) took part.

Prague/Czech Republic – Zentiva Group and Siyiara Enterprises have recently signed a Shared Purchase Agreement for the acquisition of Romanian based pharmaceutical company Solacium, together with it...

Lupin has indicated it has received another FDA warning letter as regulatory issues continue to pile up for the Indian drugmaker.

In one example, the letter said that the facility had received “numerous complaints for damage to functional coating on pantoprazole delayed release tablets” which could affect dissolution.

BEIJING, March 12 (Xinhua) -- A recent study has shown that long-term exposure to PM2.

A new alternative to statins could help hundreds of thousands of people at risk of heart disease, research suggests.

Collaboration gives Merck KGaA access to Iktos AI technology across three drug discovery projects.